MYNVAX
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig.
MYNVAX
Social Links:
Industry:
Biotechnology Health Care
Founded:
2017-05-05
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.mynvax.com
Total Employee:
1+
Status:
Active
Total Funding:
4.13 M USD
Similar Organizations
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Current Employees Featured
Founder
Investors List
Accel
Accel investment in Series A - Mynvax
Kotak Investment Advisors
Kotak Investment Advisors investment in Series A - Mynvax
1Crowd
1Crowd investment in Series A - Mynvax
LetsVenture
LetsVenture investment in Series A - Mynvax
Ajith Sukumaran
Ajith Sukumaran investment in Angel Round - Mynvax
Official Site Inspections
http://www.mynvax.com
- Host name: 106.51.79.41.actcorp.in
- IP address: 106.51.79.41
- Location: Bengaluru India
- Latitude: 12.9721
- Longitude: 77.5933
- Timezone: Asia/Kolkata
- Postal: 560002
